LRRK2 and Mental deterioration: LRRK2 mutation carriers usually present with lower risk of cognitive decline [22, 23] than IPD patients, and in general cognitive decline and psychiatric features are rarely reported in symptomatic LRRK2 mutation carriers [22, 24].